GN Media

Skip to content

Home Services Guides Contact

Breaking blockchain, crypto, tech, and finance news daily! Follow and stay ahead.

gnmedia@gnclubventures.com

CompanyAbout Short Guides Privacy Terms

Part of GN Club VenturesMazal GN Ventures GN Labs GN Club GN Media

Follow

© 2026 GN Media. All rights reserved.

NEWS. INSIGHTS. FUTURE.

Breaking blockchain, crypto, tech, and finance news daily! Follow and stay ahead.

gnmedia@gnclubventures.com

CompanyAbout Short Guides Privacy Terms

Part of GN Club VenturesMazal GN Ventures GN Labs GN Club GN Media

Follow

© 2026 GN Media. All rights reserved.

NEWS. INSIGHTS. FUTURE.

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials | GN Media

techTechCrunch

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

September 23, 2026

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

GN Media aggregates headlines — read the full story on TechCrunch.

Read full story on TechCrunch